Advancement in Physiotherapy

There has been renewed interest in the spondyloarthropathy family of chronic inflammatory Pain medication conditions, which has been fueled to a large extent by the biologic era. Over the period of the past 2 years in particular, there have been several notable advances. First, there have been a number of large, high-quality randomized controlled trials evaluating the tumor necrosis factor (TNF) blockers and conservative treatments such as physiotherapy and non-steroidal anti-inflammatory drugs for use in spondyloarthropathy. Operant behavioral and cognitive-behavioral treatment for chronic low back pain

    Related Conference of Advancement in Physiotherapy

    June 06-07, 2018

    International Conference on Fitness and Expo

    Philadelphia, Pennsylvania, USA
    August 15-16, 2018

    8th World Physiotherapists and Physicians Summit

    Tokyo, Japan
    November 19-20, 2018

    6th International Conference on Physiotherapy

    Bangkok, Thailand

    Advancement in Physiotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in